NDC 65862-106 – Efavirenz
Efavirenz 200 mg/1 · Capsule · Oral
Product NDC65862-106
Product details
- Brand name
- Efavirenz
- Generic name
- Efavirenz
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA078064
- Marketed since
- December 15, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Efavirenz 200 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 65862-106-09 | 9 BLISTER PACK in 1 CARTON (65862-106-09) / 10 CAPSULE in 1 BLISTER PACK | Dec 15, 2017 |
| 65862-106-10 | 3 BLISTER PACK in 1 CARTON (65862-106-10) / 10 CAPSULE in 1 BLISTER PACK | Dec 15, 2017 |
| 65862-106-30 | 30 CAPSULE in 1 BOTTLE (65862-106-30) | Dec 15, 2017 |
| 65862-106-90 | 90 CAPSULE in 1 BOTTLE (65862-106-90) | Dec 15, 2017 |
Other Efavirenz products
- 65862-104 Efavirenz 50 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-105 Efavirenz 100 mg/1 · Capsule · Aurobindo Pharma Limited
- 65862-049 Efavirenz 600 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 31722-504 Efavirenz 600 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 69097-301 Efavirenz 600 mg/1 · Tablet, Film Coated · Cipla USA Inc.
- 33342-013 Efavirenz 600 mg/1 · Tablet · Macleods Pharmaceuticals Limited
- 72865-172 Efavirenz 600 mg/1 · Tablet, Film Coated · XLCare Pharmaceuticals Inc.